Highbridge Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,339
Closed -$274K 1766
2017
Q2
$274K Buy
+10,339
New +$276K ﹤0.01% 994
2016
Q4
Sell
-40,847
Closed -$925K 1584
2016
Q3
$925K Sell
40,847
-1,631
-4% -$35.6K 0.01% 592
2016
Q2
$804K Buy
+42,478
New +$887K 0.01% 676
2015
Q3
Sell
-33,449
Closed -$1M 1802
2015
Q2
$1M Buy
+33,449
New +$942K 0.01% 732
2015
Q1
Sell
-33,202
Closed -$738K 1579
2014
Q4
$738K Buy
+33,202
New +$788K 0.01% 726

Other funds holding TBI

Highbridge Capital Management's TBI Position: Q3 2017 in Review

Highbridge Capital Management sold out of Trueblue (TBI) in Q3 2017, closing a stake of 10,339 shares — an estimated $274K sold.

Highbridge Capital Management first reported a position in TBI in Q4 2014 and held it in 5 quarters. The position peaked at $1M in Q2 2015. 191 funds tracked by Wall St. Rank hold TBI as of Q3 2017.

  • Highbridge Capital Management reported no remaining Trueblue position as of Q3 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 10,339 Trueblue shares in Q3 2017, an estimated $274K.
  • Highbridge Capital Management first reported a position in Trueblue in Q4 2014 and held it in 5 quarters.
  • Highbridge Capital Management's Trueblue position peaked at $1M in Q2 2015.
  • 191 funds tracked by Wall St. Rank held Trueblue as of Q3 2017.

Based on Highbridge Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.